S
Somayeh Pouyanfard
Researcher at University of California, San Diego
Publications - 17
Citations - 289
Somayeh Pouyanfard is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Immunogenicity & Induced pluripotent stem cell. The author has an hindex of 9, co-authored 14 publications receiving 221 citations. Previous affiliations of Somayeh Pouyanfard include German Cancer Research Center & Tarbiat Modares University.
Papers
More filters
Journal ArticleDOI
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against Influenza A virus challenge
Hamidreza Hashemi,Somayeh Pouyanfard,Mojgan Bandehpour,Zahra Noroozbabaei,Bahram Kazemi,Xavier Saelens,Talat Mokhtari-Azad +6 more
TL;DR: It is concluded that display of M2e on the surface of T7 phage nanoparticles offers an efficient and economical opportunity to induce cross-protective M 2e-based immunity against influenza A.
Journal ArticleDOI
Development of innate immune cells from human pluripotent stem cells.
TL;DR: Mouse and human pluripotent stem cells have been widely used to study the development of the hematopoietic and immune systems, and immune cells such as natural killer cells and macrophages can be easily produced from PSCs to enable development of new cell-based therapies.
Journal ArticleDOI
Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine.
TL;DR: A dose-response relationship was observed in both arms of immune responses induced by recombinant filamentous phage inoculation, and the results were similar to those from DNA vaccination.
Journal ArticleDOI
Human papillomavirus first and second generation vaccines-current status and future directions.
Somayeh Pouyanfard,Martin Müller +1 more
TL;DR: The current status of licensed VLP vaccines are summarized, questions related to second and third generation HPV vaccines are addressed, and researchers are seeking to overcome limitations of the V LP vaccines.
Journal ArticleDOI
Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
Somayeh Pouyanfard,Gloria Spagnoli,Lorenzo Bulli,Kathrin Balz,Fan Yang,Caroline Odenwald,Hanna Seitz,Filipe Mariz,Angelo Bolchi,Simone Ottonello,Martin Müller +10 more
TL;DR: The development of a thermostable thioredoxin-based single-peptide vaccine carrying an L2 polytope of up to 11 different HPV types that have excellent abilities in respect to broadness of protection and robustness of induced immune responses and addition of a heptamerization domain significantly increased the immunogenicity.